|
|
|
|
||
|
||
|
Vol. 7, Nos. 1-43, pp. 1-1268 Jan. 2 -- Oct. 30, 2009 # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Abbott Biotechnology Ltd. v. Centocor Ortho Biotech Inc. (D. Mass.), 526
Abbott GmbH & Co. KG v. Centocor Ortho Biotech Inc. (D. Mass.), 939 Abbott Labs.; Alabama v. (Ala. Cir. Ct.), 40; 227; 610 Abbott Labs.; Bayer HealthCare LLC v. (E.D. Tex.), 41 Abbott Labs.; Centocor Inc. v. (E.D. Tex.), 585; 671; 767 Abbott Labs.; Doe 1 v. (9th Cir.), 791; 987 Abbott Labs.; Illinois v. (Ill. Cir. Ct.), 882 Abbott Labs.; Kaiser Found. Health Plan Inc. v. (9th Cir.), 91 Abbott Labs.; Louisiana Wholesale Drug Co. v. (D. Del.), 500 Abbott Labs. v. Sandoz Inc. (Fed. Cir.), 605 Abbott Labs.; State v. (Ill. Cir. Ct.), 821 Abbott Labs.; Wisconsin v. (Wis. Cir. Ct.), 11 Abbott Labs. Norvir Antitrust Litig., In re (N.D. Cal.), 942 Abdullahi v. Pfizer Inc. (2d Cir.), 147; (U.S., rev sought), 854 Abraxis Bioscience Inc. v. Navinta LLC (D.N.J.), 907; 1035 Accord Healthcare Inc.; AstraZeneca Pharms. LP v. (D.N.J.), 203 Accutane Prod. Liab. Litig., In re (M.D. Fla.), 1039 Acker v. Schering-Plough Corp. (E.D. Tex.), 1102 Actavis Elizabeth LLC; Eli Lilly and Co. v. (D.N.J.), 609 Actavis Elizabeth LLC v. Johnson (D.D.C.), 253; 434 Actavis South Atl. LLC; Endo Pharm. Inc. v. (D.N.J.), 230 Actavis Totowa LLC; Criss v. (E.D. Tex.), 502 Actavis Totowa LLC; Myers-Armstrong v. (N.D. Cal.), 529 Actavis Totowa LLC; U.S. v. (D.N.J.), 61 Actimmune Mktg. Litig., In re (N.D. Cal.), 583 Adamu v. Pfizer Inc. (Conn. Super. Ct.), 616 Adolor Corp. Derivative Litig., In re (E.D. Pa.), 615 AFSCME Alabama; AstraZeneca v. (Ala.), 1222 Alaska Elec. Pension Fund v. Pharmacia Corp. (3d Cir.), 150 Albany Molecular Research Inc. v. Dr. Reddy's Labs. Inc. (D.N.J.), 1100 Albany Molecular Research Inc. v. Sandoz Inc. (D.N.J.), 1100 Albrecht v. Pfizer Inc. (N.D. Tex.), 1072 Alcon Labs. Inc.; RxUSA Wholesale Inc. v. (E.D.N.Y.), 1132 Alcon Labs. Ltd.; Elan Pharma Intl. Ltd. v. (E.D. Tex.), 119 Alcon Research Ltd. v. Apotex Inc. (S.D. Ind.), 202 Alcon Research Ltd. v. Barr Labs. Inc. (S.D. Ind.), 63 Alcon Research Ltd. v. Sandoz Inc. (S.D. Ind.), 202 Alderfer v. Breg Inc. (D. Colo.), 914 Allergan Inc. v. Sandoz Inc. (E.D. Tex.), 438 Allergan Inc. v. U.S. (D.D.C.), 1163 Alphapharm Pty. Ltd. v. Takeda Chem. Indus. Ltd. (U.S., rev den), 1166 Alpha Therapeutic Corp.; Texas ex rel. Ven-A-Care of the Fla. Keys Inc. v. (Tex. Dist. Ct.), 969 Altana Pharma AG v. Teva Pharms. USA Inc. (Fed. Cir.), 585 Alza Corp. v. Impax Labs. Inc. (D. Del.), 364 American Fed'n of State, County and Mun. Employees American Soc'y of Health Sys. Pharmacists; Containment Techs. Group Inc. v. (S.D. Ind.), 405 Amgen Inc. v. Ariad Pharms. Inc. (Fed. Cir.), 635 Amgen Inc. v. F. Hoffmann-La Roche Ltd. (Fed. Cir.), 1097 Amgen Inc. v. International Trade Comm'n (Fed. Cir.), 524 Amgen Inc.; U.S. v. (D. Mass.), 255 Amgen Inc.; Wisconsin v. (Wis. Cir. Ct.), 200; 556 Amphastar Pharms. Inc.; Aventis Pharma SA v. (U.S., rev sought), 171; (rev den), 495 Androgel Antitrust Litig., In re (JPML), 671 Andrx Pharms. Inc.; Elan Corp. PLC v. (S.D. Fla.), 284 Apotex Inc.; Alcon Research Ltd. v. (S.D. Ind.), 202 Apotex Inc. v. AstraZeneca AB (U.S., rev sought), 147; (rev den), 282 Apotex Inc.; AstraZeneca Pharms. LP v. (D.N.J.), 436; 461; 610 Apotex Inc.; Colacicco v. (U.S., vac), 280; (3d Cir.), 497; 498; (E.D. Pa.), 1032; 1066 Apotex Inc.; Daiichi Sankyo Co. v. (D.N.J.), 636 Apotex Inc. v. Janssen Pharmaceutica NV (U.S., rev den), 340 Apotex Inc. v. Minister of Health (Canada, Fed. Ct.), 897 Apotex Inc.; Ortho-McNeil Pharm. Inc. v. (D.N.J.), 607 Apotex Inc.; Pfizer Inc. v. (N.D. Ill.), 703 Apotex Inc. v. Roche Palo Alto LLC (U.S., rev den), 117 Apotex Inc. v. Sanofi-Synthelabo (U.S., rev sought), 912 Apotex Inc.; Unigene Labs. Inc. v. (S.D.N.Y.), 1028 Aredia and Zometa Prods. Liab. Litig., In re (M.D. Tenn.), 995 Ariad Pharms. Inc.; Amgen Inc. v. (Fed. Cir.), 635 Ariad Pharms. Inc. v. Eli Lilly and Co. (Fed. Cir.), 172; 399; 988 Arkansas Carpenters Health and Welfare Fund v. Bayer AG (U.S., rev den), 730; (2d Cir.), 790 Ash v. Providence Hosp. (S.D. Ala.), 255 Ashley County, Ark. v. Pfizer Inc. (8th Cir.), 39 Astellas Pharma Inc. v. Impax Labs. Inc. (N.D. Cal.), 1195 Astellas Pharma U.S. Inc. v. FDA (D.D.C.), 967 Astra USA Inc.; Santa Clara County v. (N.D. Cal.), 611 AstraZeneca v. Alabama (Ala.), 1222 AstraZeneca; Kentucky v. (Ky. Cir. Ct.), 1222 AstraZeneca AB; Apotex Inc. v. (U.S., rev sought), 147; (rev den), 282 AstraZeneca AB v. Dr. Reddy's Labs. Ltd. (S.D.N.Y.), 309 AstraZeneca Pharms. LP v. Accord Healthcare Inc. (D.N.J.), 203 AstraZeneca Pharms. LP v. Apotex Inc. (D.N.J.), 436; 461; 610 AstraZeneca Pharms. LP; Blue Cross Blue Shield of Mass. v. (1st Cir.), 1125 AstraZeneca Pharms. LP; Guinn v. (M.D. Fla.), 152 AstraZeneca Pharms. LP; Haller v. (M.D. Fla.), 152 AstraZeneca Pharms. LP; New Mexico v. (D.N.M.), 852 AstraZeneca Pharms. LP; Pennsylvania Employees Benefit Trust Fund v. (M.D. Fla.), 880 AstraZeneca Pharms. LP; Scaife v. (Del. Super. Ct.), 734 AstraZeneca Pharms. LP v. Teva Pharms. USA Inc. (Fed. Cir.), 1127 AstraZeneca Sec. Litig., In re (2d Cir.), 770 Attorney Gen. of Canada; Pfizer Canada Inc. v. (Canada, Fed. Ct.), 898 Avandia Mktg. Sales Practices and Prods. Liab. Litig., In re (E.D. Pa.), 284; 826 Aventis Pharma SA v. Amphastar Pharms. Inc. (U.S., rev sought), 171; (rev den), 495 Aventis Pharms. Inc. v. Sun Pharms. Indus. Ltd. (D.N.J.), 119 Aventis Pharms. Inc.; U.S. ex rel. Kennedy v. (N.D. Ill.), 501 Avon Pension Fund v. GlaxoSmithKline PLC (S.D.N.Y.), 992 Axonyx Sec. Litig., In re (S.D.N.Y.), 369 Ayotte; IMS Health Inc. v. (U.S., rev sought), 363; (rev den), 763 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |
